Edaravone administration and its potential association with a new clinical syndrome in cerebral infarction patients: Three case reports.
World journal of clinical cases(2023)
摘要
Our cases highlight the importance of educating clinicians regarding the new edaravone-induced clinical syndromes of cerebral infarction as potentially fatal adverse drug reactions. Considering that no laboratory or confirmatory test exists to diagnose edaravone-induced death from cerebral infarction, clinicians' knowledge is the key element in recognizing this phenomenon.
更多查看译文
关键词
cerebral infarction patients,new clinical syndrome
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要